Expertise

Judith Heimbürger is an experienced lawyer specialising in providing comprehensive advice to clients in the life sciences sector. She focuses in particular on drafting and negotiating complex contracts such as cross-border supply and license agreements, research and development agreements, cooperation agreements and contracts for clinical trials. In addition, she has extensive experience in providing legal advice on regulatory issues relating to pharmaceuticals (including medical cannabis), medical devices, treatment platforms, cooperation with doctors and pharmacists, drug advertising law and M&A transactions in the life sciences sector.

Judith Advises

  • National and international companies in the life sciences sector, from start-ups to listed
    companies, in particular in the fields of pharmaceuticals, diagnostics, medical devices and biotechnology as well as investors in this field
  • Pharmacists and doctors, in particular on professional law issues when practicing via online platforms

Experience Highlights

  • German medium-sized API manufacturer: Legal advice and support in the negotiation of complex agreement structures, such as worldwide supply and license agreements with different partners
  • Canopy Growth Corp.: Advising a subsidiary of one of the leading Canadian medical cannabis suppliers on the acquisition of the German inhaler manufacturer Storz & Bickel GmbH & Co. KG for €135 million
  • Canadian medical cannabis supplier: Advising on the conclusion of a joint venture agreement with a German pharmaceutical wholesaler.
  • Large US medical devices manufacturer: Advising on CE marking, reclassification and other regulatory issues
  • Large US medical devices manufacturer: Advising on compliance issues in the context of clinical trials of medical devices.
  • International biotechnology company: Advising on several agreements (agreement on contract research, supply agreement)
  • German affiliate of a large international pharmaceutical company: Advising on various matters (e.g. supply and storage agreements)
  • A spin-off from a German university: Advising on various agreements (e.g., confidentiality and material transfer agreements, cooperation agreements) as well as issues concerning the German law on employees’ inventions
  • A German biotechnology company: Advising on a cooperation agreement concerning conducting a non-commercial clinical trial

Career History

Previous Law firms

  • 02/2012-12/2024: Lawyer at Dentons Europe (Germany) GmbH & Co. KG
  • 02/2012-07/2012: Trainee
  • 08/2012-03/2015: Associate
  • 04/2015-09/2023: Senior Associate
  • 10/2023-12/2024: Counsel

Memberships

  • German Bar Association (Deutscher Anwaltsverein (DAV))
  • Frankfurt Bar Association (Frankfurter Anwaltsverein e.V.)

Education

  • University of Bayreuth (legal studies with an additional qualification in economics (Wirtschaftsjuristin (Univ. Bayreuth))
  • Qualification as Business Mediator (Wirtschaftsmediatorin (CVM))

Other

  • “Current Case Law on Treatment Platforms for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 6 (co-author), November 2024
  • “Online Platforms for Medical Cannabis Treatment and Legal Pitfalls”, The Legal Industry Reviews Germany, Edition 4 (co-author), February 2024
  • “Draft Bill German Cannabis Law – Consequences for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 2 (co-author), September 2023
  • “Neuer Vorstoß zur Bekämpfung der Korruption im Gesundheitswesen”, Science4Life (co-author), 2015
  • “Auftragsforschung – Zu welchem Preis? ”, GoingPublic Magazin – Special “Biotechnologie” 2015 (co-author), 2015
  • “Bekämpfung von Korruption im Gesundheitswesen”, ZRFC 3/15, (co-author), 2015
  • “Auslizenzierungspraxis von Universitäten”, Platow Recht, Nr. 112, (co-author), 2014
  • “IP Flash – The new TTBER: Changes of Termination Clauses”, Euro Biotech News (co-author), 2014
  • “Die neue GVO-TT – Überblick und Auswirkungen, Technologietransfer”, transkript, (co-author), 2014
  • “Von „One-Size-fits-All“ zur maßgeschneiderten Therapie, Rechtliche Harmonisierungsbemühungen im Bereich der personalisierten Medizin”, GoingPublic Life Sciences, (co-author), 2014
  • “Fernabsatzverträge für Arzneimittel, Retoure: Verbraucherschutz vor Arzneimittelsicherheit? ”, transkript, Nr. 11, (co-author), 2013
  • “Das rechtliche Umfeld bei Companion Diagnostics”, Venture Capital, Sonderbeilage „Personalisierte Medizin“ (co-author), 2013

 

 

 

Judith is a lawyer in gunnercooke GmbH, whose registered office is Kurfuerstendamm 15, 10719 Berlin, AG Charlottenburg, HRB 224488 B. All lawyers of gunnercooke GmbH are admitted either in Germany or Austria to practise as Rechtsanwalt or Rechtsanwaeltin and are members of and regulated by the relevant local Bar (Rechtsanwaltskammer).

Expertise

Back to top

Judith Heimbürger is an experienced lawyer specialising in providing comprehensive advice to clients in the life sciences sector. She focuses in particular on drafting and negotiating complex contracts such as cross-border supply and license agreements, research and development agreements, cooperation agreements and contracts for clinical trials. In addition, she has extensive experience in providing legal advice on regulatory issues relating to pharmaceuticals (including medical cannabis), medical devices, treatment platforms, cooperation with doctors and pharmacists, drug advertising law and M&A transactions in the life sciences sector.

Judith Advises

Back to top

  • National and international companies in the life sciences sector, from start-ups to listed
    companies, in particular in the fields of pharmaceuticals, diagnostics, medical devices and biotechnology as well as investors in this field
  • Pharmacists and doctors, in particular on professional law issues when practicing via online platforms

Experience Highlights

Back to top

  • German medium-sized API manufacturer: Legal advice and support in the negotiation of complex agreement structures, such as worldwide supply and license agreements with different partners
  • Canopy Growth Corp.: Advising a subsidiary of one of the leading Canadian medical cannabis suppliers on the acquisition of the German inhaler manufacturer Storz & Bickel GmbH & Co. KG for €135 million
  • Canadian medical cannabis supplier: Advising on the conclusion of a joint venture agreement with a German pharmaceutical wholesaler.
  • Large US medical devices manufacturer: Advising on CE marking, reclassification and other regulatory issues
  • Large US medical devices manufacturer: Advising on compliance issues in the context of clinical trials of medical devices.
  • International biotechnology company: Advising on several agreements (agreement on contract research, supply agreement)
  • German affiliate of a large international pharmaceutical company: Advising on various matters (e.g. supply and storage agreements)
  • A spin-off from a German university: Advising on various agreements (e.g., confidentiality and material transfer agreements, cooperation agreements) as well as issues concerning the German law on employees’ inventions
  • A German biotechnology company: Advising on a cooperation agreement concerning conducting a non-commercial clinical trial

Career History

Back to top

Previous Law firms

  • 02/2012-12/2024: Lawyer at Dentons Europe (Germany) GmbH & Co. KG
  • 02/2012-07/2012: Trainee
  • 08/2012-03/2015: Associate
  • 04/2015-09/2023: Senior Associate
  • 10/2023-12/2024: Counsel

Memberships

  • German Bar Association (Deutscher Anwaltsverein (DAV))
  • Frankfurt Bar Association (Frankfurter Anwaltsverein e.V.)

Education

  • University of Bayreuth (legal studies with an additional qualification in economics (Wirtschaftsjuristin (Univ. Bayreuth))
  • Qualification as Business Mediator (Wirtschaftsmediatorin (CVM))

Other

  • “Current Case Law on Treatment Platforms for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 6 (co-author), November 2024
  • “Online Platforms for Medical Cannabis Treatment and Legal Pitfalls”, The Legal Industry Reviews Germany, Edition 4 (co-author), February 2024
  • “Draft Bill German Cannabis Law – Consequences for Medical Cannabis”, The Legal Industry Reviews Germany, Edition 2 (co-author), September 2023
  • “Neuer Vorstoß zur Bekämpfung der Korruption im Gesundheitswesen”, Science4Life (co-author), 2015
  • “Auftragsforschung – Zu welchem Preis? ”, GoingPublic Magazin – Special “Biotechnologie” 2015 (co-author), 2015
  • “Bekämpfung von Korruption im Gesundheitswesen”, ZRFC 3/15, (co-author), 2015
  • “Auslizenzierungspraxis von Universitäten”, Platow Recht, Nr. 112, (co-author), 2014
  • “IP Flash – The new TTBER: Changes of Termination Clauses”, Euro Biotech News (co-author), 2014
  • “Die neue GVO-TT – Überblick und Auswirkungen, Technologietransfer”, transkript, (co-author), 2014
  • “Von „One-Size-fits-All“ zur maßgeschneiderten Therapie, Rechtliche Harmonisierungsbemühungen im Bereich der personalisierten Medizin”, GoingPublic Life Sciences, (co-author), 2014
  • “Fernabsatzverträge für Arzneimittel, Retoure: Verbraucherschutz vor Arzneimittelsicherheit? ”, transkript, Nr. 11, (co-author), 2013
  • “Das rechtliche Umfeld bei Companion Diagnostics”, Venture Capital, Sonderbeilage „Personalisierte Medizin“ (co-author), 2013

 

 

 

Judith is a lawyer in gunnercooke GmbH, whose registered office is Kurfuerstendamm 15, 10719 Berlin, AG Charlottenburg, HRB 224488 B. All lawyers of gunnercooke GmbH are admitted either in Germany or Austria to practise as Rechtsanwalt or Rechtsanwaeltin and are members of and regulated by the relevant local Bar (Rechtsanwaltskammer).